Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2023 · 1 min read
In brief
In brief
This study demonstrates that gadolinium-based contrast media does not significantly improve interobserver agreement when assessing image-defined risk factors in pediatric neuroblastoma staging. The findings suggest MRI without contrast may be sufficient for baseline neuroblastoma evaluation, potentially reducing costs and avoiding contrast-related adverse effects.
Written by the GCMD Library team from the article.
Statements in this article
Neuroblastoma risk stratification relies on prognostic risk factors and image-defined risk factors (IDRFs).
Pre-contrast versus post-contrast MRI showed excellent agreement for tumor measurement.
Overlapping confidence intervals were seen in nearly all categories of interobserver agreement on the presence or absence of individual IDRFs, with agreement ranging from poor to substantial, regardless of the presence of contrast.
The overall interobserver agreement on the presence of at least one IDRF was substantial with contrast.